Wesley A. Cheng
- Co-authors
- Hong QinLarry W. KwakZhenyuan DongD. Lynne SmithGuo‐Wei WeiHan SunPia S. PannarajYijun Liu
- Topics
- SARS-CoV-2 and COVID-19 Research (7 papers)CAR-T cell therapy research (6 papers)COVID-19 Clinical Research Studies (3 papers)
- Journals
- BloodPLoS ONEPEDIATRICS
- Partner nations
- United StatesChinaJapan
In The Last Decade
Wesley A. Cheng
17 papers receiving 267 citations
Peers
Comparison fields: 5 of 64
- Oncology 117
- Immunology 100
- Infectious Diseases 47
- Molecular Biology 46
- Obstetrics and Gynecology 35
Countries citing papers authored by Wesley A. Cheng
This map shows the geographic impact of Wesley A. Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wesley A. Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wesley A. Cheng more than expected).
Fields of papers citing papers by Wesley A. Cheng
This network shows the impact of papers produced by Wesley A. Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wesley A. Cheng. The network helps show where Wesley A. Cheng may publish in the future.
Co-authorship network of co-authors of Wesley A. Cheng
This figure shows the co-authorship network connecting the top 25 collaborators of Wesley A. Cheng. A scholar is included among the top collaborators of Wesley A. Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wesley A. Cheng. Wesley A. Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 4 | |
| 3 | 1 | |
| 4 | 9 | |
| 5 | 12 | |
| 6 | 27 | |
| 7 | 31 | |
| 8 | 17 | |
| 9 | 3 | |
| 10 | 17 | |
| 11 | Measuring the Robustness of the National Basketball Association Home Court Advantage Effect | 1 |
| 12 | 1 | |
| 13 | 91 | |
| 14 | 24 | |
| 15 | 2 | |
| 16 | 1 | |
| 17 | 27 |
About Wesley A. Cheng
Wesley A. Cheng is a scholar working on Infectious Diseases, Oncology and Obstetrics and Gynecology, having authored 17 papers that have together received 270 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (7 papers), CAR-T cell therapy research (6 papers) and COVID-19 Clinical Research Studies (3 papers). The work is most often cited by research in Immunology (100 citations), Obstetrics and Gynecology (35 citations) and Oncology (117 citations). Wesley A. Cheng has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Hong Qin, Larry W. Kwak, Zhenyuan Dong, D. Lynne Smith, Guo‐Wei Wei, Han Sun, Pia S. Pannaraj, Yijun Liu, Soung-Chul Cha and Jacob E. Montgomery. Their work appears in journals such as Blood, PLoS ONE and PEDIATRICS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.